Tag:Oxford Cannabinoid Technologies

European Cannabis Stocks Review: LSE-Listed Cannabis Stocks Enjoy Unexpected Comeback As Cellular Goods Jumps 40%

In further signs of positive momentum, UK listed cannabis stocks made an unexpected comeback this week, following months of unrelenting share price losses across...

European Cannabis Industry ‘Potentially An Even Bigger Opportunity’ Than The US, And Investors Should ‘Wake Up To The Opportunities In Their Own Backyard’

NORTH American investment in the European cannabis industry has grown at pace over the last few years, with hundreds of millions in capital flooding...

Oxford Cannabinoid Technologies Releases Update On Its Two Lead Compounds

OXFORD Cannabinoid Technologies Holdings plc (LSE: OCTP, OTCQB: OCTHF), the pharmaceutical company developing prescription cannabinoid medicines targeting the US$ multi-billion pain market is pleased...

OCT Co-Founder Publishes Scathing Letter Accusing Directors of ‘Serious Governance & Management’ Failings Ahead of GM Vote to Oust Board

GAVIN Sathianathan, a founder member of Oxford Cannabinoid Technologies (OCT), published a bombshell letter to fellow investors last week laying bare the numerous reasons...

EU Cannabis Stocks Review: OCT Board Accused of Serious Governance Issues by Co-Founder, Panaxia’s Debt Pile Hits Stock & More from Love Hemp

AS European Cannabis stocks continue their battle against external market forces, it has been internal battles which made the headlines this week.  Major stakeholders of...

One Year After The First Cannabis Stocks Joined The LSE, Could We See A Fresh Run Of Cannabis IPOs This Year?

FEBRUARY 2022 marked the one-year anniversary of MGC Pharmaceuticals IPO on the London Stock Exchange, which saw cannabis stocks traded on the platform for the first time in its 320-year history. 

Oxford Cannabinoid Technologies Says Data From Pre-Clinical Study of Leading Drug Candidate Shows Positive Results

OXFORD Cannabinoid Technologies Holdings plc (LSE: OCTP, OTCQB: OCTHF), the pharmaceutical company developing prescription cannabinoid medicines targeting the US$ multi-billion pain market is pleased...

EU Cannabis Stocks Review: Love Hemp jumps 60%, OCT sees recovery & more from Cellular Goods, Chill Brands and MGC Pharma

On the 1-year anniversary of the first cannabis company to list on the London Stock Exchange, we examine the reaction to a number of significant announcements from some of the UK’s biggest cannabis players, making for an eventful week in the markets. 

Latest news

British People Open To Using Medical Cannabis – Yet Majority Unaware They Can Access It On Prescription 

A NEW national survey of 4,000 people has highlighted the need to improve awareness of cannabis as a medicine.  Key...
- Advertisement -spot_imgspot_img

As US Hemp Cultivation Levels Plummet The Established European Industry Continues To Flourish 

DESPITE a huge decline in US hemp industry’s footprint the European industry will continue to grow, say the continent’s...

Chrystal Capital Acts As Exclusive Advisor To Change Agronomy On £9.6m Fundraise

CHRYSTAL Capital Partners LLP, is an entrepreneurial corporate finance and investment house with an established global network of Single...

Must read

As US Hemp Cultivation Levels Plummet The Established European Industry Continues To Flourish 

DESPITE a huge decline in US hemp industry’s footprint...

European Cannabis Stocks Review: ‘End’ Of US Cannabis Bear Market Rallies European Stocks 

FOLLOWING last week’s rally there has seen something of...